SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

07 Feb 2022 Evaluate
The company witnessed a 22.35% growth in the revenue at Rs. 2002.24 millions for the quarter ended December 2021 as compared to Rs. 1636.43 millions during the year-ago period.The Total revenue for the quarter ended December 2021 of  Rs. 123.80  millions  grew by 269.11% from Rs. 33.54 millions.The company reported a good operating profit of 303.76 millions compared to 192.75 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 2002.24 1636.43 22.35 4841.19 4315.89 12.17 6000.48 5797.79 3.50
Other Income 72.48 14.15 412.23 120.89 37.31 224.02 77.16 240.64 -67.94
PBIDT 303.76 192.75 57.59 573.49 449.59 27.56 695.88 798.79 -12.88
Interest 64.49 80.99 -20.37 235.41 226.16 4.09 347.85 241.71 43.91
PBDT 239.27 111.76 114.09 338.08 218.40 54.80 343.00 525.67 -34.75
Depreciation 67.22 62.81 7.02 197.85 127.21 55.53 192.83 112.82 70.92
PBT 172.05 48.95 251.48 140.23 91.19 53.78 150.17 412.85 -63.63
TAX 48.25 15.41 213.11 39.00 29.75 31.09 67.37 105.64 -36.23
Deferred Tax 16.83 6.25 169.28 13.39 12.94 3.48 39.58 30.64 29.18
PAT 123.80 33.54 269.11 101.23 61.44 64.76 82.80 307.21 -73.05
Equity 127.63 127.47 0.13 127.63 127.47 0.13 127.50 121.25 5.15
PBIDTM(%) 15.17 11.78 28.80 11.85 10.42 13.72 11.60 13.78 -15.83

Camlin Fine Sciences Share Price

130.65 -1.20 (-0.91%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3628.65
Tata Chemicals 801.15
SRF 2527.60
Pidilite Inds. 1363.45
Deepak Nitrite 1771.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×